Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
230 | 20331 | 32.6 | 66% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ANTIEPILEPTIC DRUGS | authKW | 1306985 | 9% | 50% | 1738 |
2 | LEVETIRACETAM | authKW | 661620 | 3% | 67% | 655 |
3 | EPILEPSY | authKW | 655351 | 16% | 14% | 3167 |
4 | ANTICONVULSANTS | authKW | 496709 | 5% | 35% | 952 |
5 | EPILEPSIA | journal | 487664 | 8% | 19% | 1702 |
6 | TOPIRAMATE | authKW | 481614 | 3% | 50% | 639 |
7 | LAMOTRIGINE | authKW | 449751 | 3% | 47% | 636 |
8 | STATUS EPILEPTICUS | authKW | 449295 | 4% | 37% | 809 |
9 | GABAPENTIN | authKW | 448964 | 3% | 46% | 652 |
10 | VALPROATE | authKW | 338841 | 3% | 41% | 547 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Clinical Neurology | 183964 | 42% | 2% | 8446 |
2 | Pharmacology & Pharmacy | 29563 | 24% | 1% | 4860 |
3 | Neurosciences | 10647 | 15% | 0% | 3147 |
4 | Psychiatry | 9350 | 9% | 0% | 1774 |
5 | Toxicology | 5233 | 6% | 0% | 1127 |
6 | Medical Laboratory Technology | 4946 | 3% | 1% | 576 |
7 | Pediatrics | 4004 | 6% | 0% | 1183 |
8 | Behavioral Sciences | 2340 | 3% | 0% | 585 |
9 | Chemistry, Medicinal | 2145 | 4% | 0% | 775 |
10 | Anesthesiology | 929 | 2% | 0% | 330 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NEUROL | 65843 | 17% | 1% | 3400 |
2 | EPILEPSY UNIT | 60811 | 1% | 26% | 156 |
3 | COMPREHENS EPILEPSY | 54805 | 1% | 23% | 162 |
4 | PHARMACOL THER EUT UNIT | 51168 | 0% | 74% | 46 |
5 | HARVARD NEUROENDOCRINE UNIT | 39697 | 0% | 88% | 30 |
6 | EPILEPSY | 39222 | 1% | 10% | 275 |
7 | DAVID R BLOOM PHARM | 38651 | 0% | 31% | 84 |
8 | EPILEPSY BRANCH | 37691 | 0% | 42% | 60 |
9 | KLIN EPILEPTOL | 22591 | 0% | 38% | 40 |
10 | ISOBOLOG ANAL | 19498 | 0% | 48% | 27 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EPILEPSIA | 487664 | 8% | 19% | 1702 |
2 | EPILEPSY RESEARCH | 212744 | 4% | 19% | 742 |
3 | SEIZURE-EUROPEAN JOURNAL OF EPILEPSY | 207364 | 3% | 24% | 580 |
4 | EPILEPSY & BEHAVIOR | 88456 | 2% | 12% | 492 |
5 | THERAPEUTIC DRUG MONITORING | 67620 | 2% | 11% | 412 |
6 | EPILEPTIC DISORDERS | 29371 | 1% | 14% | 141 |
7 | NEUROLOGY | 25297 | 3% | 3% | 608 |
8 | ACTA NEUROLOGICA SCANDINAVICA | 20074 | 1% | 5% | 288 |
9 | JOURNAL OF CHILD NEUROLOGY | 14079 | 1% | 4% | 216 |
10 | JOURNAL OF EPILEPSY | 13956 | 0% | 15% | 61 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANTIEPILEPTIC DRUGS | 1306985 | 9% | 50% | 1738 | Search ANTIEPILEPTIC+DRUGS | Search ANTIEPILEPTIC+DRUGS |
2 | LEVETIRACETAM | 661620 | 3% | 67% | 655 | Search LEVETIRACETAM | Search LEVETIRACETAM |
3 | EPILEPSY | 655351 | 16% | 14% | 3167 | Search EPILEPSY | Search EPILEPSY |
4 | ANTICONVULSANTS | 496709 | 5% | 35% | 952 | Search ANTICONVULSANTS | Search ANTICONVULSANTS |
5 | TOPIRAMATE | 481614 | 3% | 50% | 639 | Search TOPIRAMATE | Search TOPIRAMATE |
6 | LAMOTRIGINE | 449751 | 3% | 47% | 636 | Search LAMOTRIGINE | Search LAMOTRIGINE |
7 | STATUS EPILEPTICUS | 449295 | 4% | 37% | 809 | Search STATUS+EPILEPTICUS | Search STATUS+EPILEPTICUS |
8 | GABAPENTIN | 448964 | 3% | 46% | 652 | Search GABAPENTIN | Search GABAPENTIN |
9 | VALPROATE | 338841 | 3% | 41% | 547 | Search VALPROATE | Search VALPROATE |
10 | VALPROIC ACID | 336018 | 3% | 34% | 651 | Search VALPROIC+ACID | Search VALPROIC+ACID |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PATSALOS, PN , BERRY, DJ , BOURGEOIS, BFD , CLOYD, JC , GLAUSER, TA , JOHANNESSEN, SI , LEPPIK, IE , TOMSON, T , PERUCCA, E , (2008) ANTIEPILEPTIC DRUGS - BEST PRACTICE GUIDELINES FOR THERAPEUTIC DRUG MONITORING: A POSITION PAPER BY THE SUBCOMMISSION ON THERAPEUTIC DRUG MONITORING, ILAE COMMISSION ON THERAPEUTIC STRATEGIES.EPILEPSIA. VOL. 49. ISSUE 7. P. 1239 -1276 | 281 | 81% | 249 |
2 | BROPHY, GM , BELL, R , CLAASSEN, J , ALLDREDGE, B , BLECK, TP , GLAUSER, T , LAROCHE, SM , RIVIELLO, JJ , SHUTTER, L , SPERLING, MR , ET AL (2012) GUIDELINES FOR THE EVALUATION AND MANAGEMENT OF STATUS EPILEPTICUS.NEUROCRITICAL CARE. VOL. 17. ISSUE 1. P. 3-23 | 195 | 88% | 226 |
3 | SARCO, DP , BOURGEOIS, BFD , (2010) THE SAFETY AND TOLERABILITY OF NEWER ANTIEPILEPTIC DRUGS IN CHILDREN AND ADOLESCENTS.CNS DRUGS. VOL. 24. ISSUE 5. P. 399-430 | 272 | 79% | 1 |
4 | TRINKA, E , HOFLER, J , LEITINGER, M , BRIGO, F , (2015) PHARMACOTHERAPY FOR STATUS EPILEPTICUS.DRUGS. VOL. 75. ISSUE 13. P. 1499 -1521 | 161 | 90% | 5 |
5 | JABBARIBAR, F , MORTAZAVI, SA , JOUYBAN, A , (2009) ANALYTICAL METHODS FOR DETERMINATION OF ANTIEPILEPTIC DRUGS.CURRENT PHARMACEUTICAL ANALYSIS. VOL. 5. ISSUE 3. P. 277-345 | 251 | 68% | 1 |
6 | TRINKA, E , HOFLER, J , LEITINGER, M , ROHRACHER, A , KALSS, G , BRIGO, F , (2016) PHARMACOLOGIC TREATMENT OF STATUS EPILEPTICUS.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 17. ISSUE 4. P. 513 -534 | 139 | 89% | 2 |
7 | PATSALOS, PN , (2013) DRUG INTERACTIONS WITH THE NEWER ANTIEPILEPTIC DRUGS (AEDS)-PART 1: PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS BETWEEN AEDS.CLINICAL PHARMACOKINETICS. VOL. 52. ISSUE 11. P. 927-966 | 144 | 89% | 31 |
8 | BATTINO, D , TOMSON, T , (2007) MANAGEMENT OF EPILEPSY DURING PREGNANCY.DRUGS. VOL. 67. ISSUE 18. P. 2727-2746 | 160 | 91% | 36 |
9 | WLODARCZYK, BJ , PALACIOS, AM , GEORGE, TM , FINNELL, RH , (2012) ANTIEPILEPTIC DRUGS AND PREGNANCY OUTCOMES.AMERICAN JOURNAL OF MEDICAL GENETICS PART A. VOL. 158A. ISSUE 8. P. 2071 -2090 | 135 | 91% | 28 |
10 | KANG, J , PARK, YS , KIM, SH , KIM, SH , JUN, MY , (2011) MODERN METHODS FOR ANALYSIS OF ANTIEPILEPTIC DRUGS IN THE BIOLOGICAL FLUIDS FOR PHARMACOKINETICS, BIOEQUIVALENCE AND THERAPEUTIC DRUG MONITORING.KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY. VOL. 15. ISSUE 2. P. 67-81 | 171 | 78% | 10 |
Classes with closest relation at Level 2 |